Willmott N, Cummings J, Florence A T
Department of Pharmacy, University of Strathclyde, Glasgow, Scotland.
J Microencapsul. 1985 Oct-Dec;2(4):293-304. doi: 10.3109/02652048509033841.
Release of adriamycin from albumin and haemoglobin microspheres has been determined in vitro using a flow through system. Release from cross-linked albumin microspheres is controlled by the percentage of glutaraldehyde used but release profiles of spheres of 23, 41 and 60 microns diameter were virtually superimposable. Not all of the adriamycin is released from the microspheres over 20 h; as biodegradation occurs in vivo after 24 h the amount of drug remaining in the system at 20 h is likely to be principally released by degradation of the protein matrix in vivo. Estimates of the retained adriamycin vary from 16-26 per cent for albumin (n = 3) and 30 per cent for haemoglobin (n = 1).
已使用流通系统在体外测定了阿霉素从白蛋白和血红蛋白微球中的释放情况。交联白蛋白微球的释放受所用戊二醛百分比的控制,但直径为23、41和60微米的微球的释放曲线实际上是重叠的。并非所有阿霉素在20小时内都从微球中释放出来;由于体内24小时后会发生生物降解,20小时时系统中残留的药物量可能主要是由体内蛋白质基质的降解释放出来的。白蛋白中保留的阿霉素估计值在16% - 26%之间(n = 3),血红蛋白中为30%(n = 1)。